VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS

Similar documents
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada

Vasopressors in septic shock

Should we use steroids in sepsis? J.G. van der Hoeven

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Vasopressors for shock

Actualités de la prise en charge hémodynamique initiale Daniel De Backer

Cardiovascular Management of Septic Shock

Timing of Vasopressors in Septic Shock: How Soon is Too Soon?

Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock

When options matter. Vasopressor Reloaded. Balance in Haemodynamics - Only Survival Matters

Sepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti

Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)

Department of Intensive Care Medicine UNDERSTANDING CIRCULATORY FAILURE IN SEPSIS

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

How to resuscitate the patient in early sepsis? A physiological approach. J.G. van der Hoeven, Nijmegen

Resuscitation Symposium Resuscitation Literature Update. Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH

Sepsis Management: Past, Present, and Future

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

Cardiogenic shock: Current management

In-hospital Care of the Post-Cardiac Arrest Patient. David A. Pearson, MD, FACEP, FAAEM Associate Program Director Department of Emergency Medicine

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis

Sepsis: Identification and Management in an Acute Care Setting

Making vasopressors safer

Sepsis and septic shock Practical hemodynamic consequences. Intensive Care Training Program Radboud University Medical Centre Nijmegen

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.

Early Goal-Directed Therapy

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Brain under pressure Impact of vasopressors

Titrating Critical Care Medications

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Heart Rate Control in sepsis and septic shock

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

OHSU. Update in Sepsis

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Inflammatory Statements

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

CORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE

Pediatric Sepsis Treatment:

BC Sepsis Network Emergency Department Sepsis Guidelines

Vasopressor hormones in shock noradrenaline, vasopressin or angiotensin II: which one will make the race?

Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya

Sepsis and septic shock

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Supplementary Appendix

Taiwan Crit. Care Med.2009;10: C 1. CVP 8~12 mmhg 2. MAP 65 mmhg 1. 1B

Update in Critical Care Medicine

Looking for sepsis. Sepsis: Update. Prevalence of High Profile Dzs. Screening and risk stratification. Mortality of High Profile Diseases

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Sepsis is a complicated infectious process that propagates. Use of Vasopressors in Septic Shock. Clinical review

Guidelines are the Future of Sepsis Management Pro

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

NE refractoriness: From Definition To Treatment... Prof. Alain Combes

JAMA. 2016;315(8): doi: /jama

Acute Liver Failure: Supporting Other Organs

Pediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee

การอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล

Novel Sepsis Therapies

Septic AKI in ICU patients

GIAPREZA (angiotensin II) Update

Sepsis. From EMS to ER to ICU. What we need to be doing

Norepinephrine (Levophed )

The Art and Science of Infusion Nursing John M. Allen, PharmD, BCPS. Understanding Vasoactive Medications

Full Disclosure. The case for why it matters. Goal-directed Fluid Resuscitation

John Park, MD Assistant Professor of Medicine

The Use of Metabolic Resuscitation in Sepsis

Early-goal-directed therapy and protocolised treatment in septic shock

How can the PiCCO improve protocolized care?

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

The subject of the best vasopressor drug for the initial

The 2016 Surviving Sepsis Guidelines have arrived, a

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

Dr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia (Spain) Pulsion MAB

Swans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall

Sepsis: Mitigating Denials Amid Definition Disparity

LJPC-501 Market Opportunity

Hemodynamic Monitoring Using Switching Autoregressive Dynamics of Multivariate Vital Sign Time Series

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Objectives. Outline. Sepsis Incidence and Outcomes. Definitions

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

Sepsis Management Update 2014

Management of Severe Sepsis:

Surviving Sepsis Campaign

Prehospital treatment of sepsis Christopher W. Seymour, MD MSc

Red Cell Transfusion triggers: A moving target When, who, and how much?

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

When Fluids are Not Enough: Inopressor Therapy

Special features of cardiogenic failure in sepsis. Krisztina Madách

Jarisch A. Kreislauffragen, Dünser et al. Critical Care 2013, 17:326 Sunday, March 30, 14

Transcription:

Department of Intensive Care Medicine VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS

SEPTIC SHOCK : THE CLINICAL SCENARIO HYPOTENSION DESPITE ADEQUATE VOLUME RESUSCITATION or ON VASOPRESSORS TO AVOID HYPOTENSION

OPEN QUESTIONS/ MAJOR CONTROVERSIES Sepsis-3 «need for vasopressors» Ö definition of blood pressure targets «adequate fluid resuscitation» JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287

THE HEMODYNAMIC TARGET BLOOD PRESSURE! Sevransky JE et al, Critical Care 2007, 11:R67 Takala et al, Intensive Care Med 2008 Aug;34:1401-10. Epub 2008 Apr 3 Torgersen et al, Eur J Anaesthesiol 2011;28:284-90

BLOOD PRESSURE TARGETS: a consensus mean arterial pressure in sepsis: 65 70 mmhg...but we do not do what we say...

BLOOD PRESSURE MANAGEMENT IN CLINICAL TRIALS 100 mean arterial blood pressure (mmhg) 90 80 70 60 50 target MAP actual MAP at 24 hrs based on trials cited in Sevransky JE et al: Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. Critical Care 2007, 11:R67

high blood pressures in clinical trials on hemodynamic management Asfar et al, N Engl J Med 2014, epublished on March 18 Russell JA et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87 De Backer D et al: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89 Annane D et al: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007 370:676-684

A CLOSER LOOK AT TRIALS WITH STRICT HEMODYNAMIC MANAGEMENT PROTOCOLS: the CATS trial Annane D et al: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007 370:676-684

TARGET MEAN ARTERIAL BLOOD PRESSURE at least 70 mmhg, thereafter stepwise vasopressor withdrawal Annane D et al Lancet 2007; 370:676 684

TIME TO VASOPRESSOR WITHDRAWAL

A CLOSER LOOK: the VASST study Russell JA et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87

MAP >85 mmhg safety limit for hypertension, rapid tapering of open label vasopressors and the study drug, if considered necessary An initial target mean arterial pressure of 65 to 75 mm Hg was recommended; however, the attending ICU physician could modify the target blood pressure of each patient Russell et al, N Engl J Med 2008;358:877-87

A CLOSER LOOK: the norepi vs dopa study De Backer D et al: Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 2010;362:779-89

The target blood pressure was determined by the doctor in charge for each individual patient De Backer et al, N Engl J Med 2010;362:779-89

A CLOSER LOOK: the SEPSISPAM study Asfar P et al High versus low blood-pressure target in patients with septic shock N Engl J Med 2014;370:1583-93

recommendation: reduce vasopressors hourly, if MAP above target Asfar et al N Engl J Med 2014;370:1583-93

BLOOD PRESSURE IN LARGE CLINICAL TRIALS a dissociation between actual and targeted blood pressure deviation towards higher blood pressure regardless of strict protocols or recommendations

PRECISION MEDICINE or PERSONALIZED MEDICINE?

PLoSONE 12(1): e0167840

FAILURE TO TITRATE (REDUCE) VASOPRESSORS Lamontagne et al, PLoSONE 12(1): e0167840

FAILURE TO TITRATE (REDUCE) VASOPRESSORS Lamontagne et al, Intensive Care Med 2016;42:542 550

80 % not clinically justified

DO HIGHER BLOOD PRESSURES MATTER? MAP-levels of 60-65 mmhg do not hurt and higher levels offer no mortality benefits Ö Ö Varpula M et al: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31:1066-1071 retrospective analysis of 111 patients Dünser MW et al: Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009;35:1225-1233. Epub 2009 Feb 3 retrospective analysis of 274 patients

DO HIGHER BLOOD PRESSURES MATTER? increased catecholamine load at MAP>70 mmhg may harm retrospective analysis of the control group in the L-NMMA phase III trial Ö adjusted for age, chronic arterial hypertension mean vasopressor load, SAPS II, geographic region, center MAP levels above 70 mmhg were not associated with 28- day mortality Dünser MW et al: Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13:R181. [Epub ahead of print]

MEAN VASOPRESSOR LOAD was associated with INCREASED RISK OF 28-DAY MORTALITY (P<.001) occurrence of disease-related adverse events Dünser MW et al: Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13:R181. [Epub ahead of print]

DO HIGHER BLOOD PRESSURES MATTER? any further increases in blood pressure above 70 mmhg achieved by catecholamine vasopressors may increase the risk of mortality

HIGH DOSE OF NOREPINEPHINE: independently associated with risk of death Martin et al, Shock 2015;44,:305 309

HIGH DOSE OF NOREPINEPHINE: independently associated with risk of death Martin et al, Shock 2015;44,:305 309

L-NMMA MAP RESPONSE IN PHASE II SUPERIMPOSED ON PHASE III L-NMMA phase III control phase III Takala J, Crit Care Med 2010; 38[Suppl.]:S613 S619

L-NMMA SURVIVAL CURVE OF PHASE II SUPERIMPOSED ON PHASE III data points for 28-day survival curve for L-NMMA in the phase II study lower MAP higher MAP control phase III L-NMMA phase III blood pressure more relevant to outcome than the drug(s)? Takala J, Crit Care Med 2010; 38[Suppl.]:S613 S619

REDUCING CATECHOLAMINE VASOPRESSORS? benefit for less severe septic shock in the VASST trial NE 5-14 µg/min protection from unnecessary exposure to catecholamines?

ADVERSE EFFECTS OF CATECHOLAMINES? excess vasoconstriction impaired microcirculation increased metabolic demands altered immune response increased myocardial oxygen demand risk of myocardial ischemia etc.

DISSOCIATION BETWEEN BLOOD FLOW AND BLOOD PRESSURE

39 Septic Patients (15,836 pulmonary artery catheter measurements) r²=0.003

TREATMENT TARGETS TO RESTORE HEMODYNAMIC STABILITY? A. Jarisch: Fortschritte der gesamten Medizin Dtsch Med Wochenschr 1928;28:1173-1213 A. Jarisch Fortschritte der gesamten Medizin IT HAS BEEN A CERTAIN DISASTER FOR THE DEVELOPMENT OF THE SCIENCE OF CIRCULATION THAT BLOOD FLOW IS SO DIFFICULT TO Dtsch MEASURE Med IN Wochenschr CONTRAST TO 1928;28:1173-1213 THE EASE OF MEASURING BLOOD PRESSURE THEREFORE, BLOOD PRESSURE MANOMETER ACHIEVED ITS EVEN FASCINATING IMPACT, DESPITE THE FACT THAT MOST ORGANS DO NOT NEED BLOOD PRESSURE THEY NEED BLOOD FLOW Rev. S. Hales 1731 2017???

CONCERNS TO BE ADDRESSED: does accepting lower MAP risk the kidney? do patients with hypertension profit from higher MAP?